UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019199
Receipt number R000022168
Scientific Title Objective evaluation of the sound therapy for the tinnitus caused by the unilateral hearing loss -exploratory observation by means of magnetoencephalography-
Date of disclosure of the study information 2015/10/15
Last modified on 2017/04/01 12:37:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Objective evaluation of the sound therapy for the tinnitus caused by the unilateral hearing loss -exploratory observation by means of magnetoencephalography-

Acronym

Neuromagnetic evaluation for the sound therapy for the tinnitus

Scientific Title

Objective evaluation of the sound therapy for the tinnitus caused by the unilateral hearing loss -exploratory observation by means of magnetoencephalography-

Scientific Title:Acronym

Neuromagnetic evaluation for the sound therapy for the tinnitus

Region

Japan


Condition

Condition

tinnitus

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Elucidation of the background mechanism of the effects of sound therapy for tinnitus

Basic objectives2

Others

Basic objectives -Others

elucidation

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

auditory evoked fields

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

measurements of auditory evoked fields
(the time required for measurements: 1.5 hours, the number of measurements:2, time of measuremnets:before and 6 months after initiation of therapy)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) tinnitus patients with unilateral hearing loss treated by sound therapy (voluntary participants)
2) THI score >= 58/100
3) age >= 20 years old
4) Peformance status = 0 or 1

Key exclusion criteria

1) Peripheral or central neurological diorders
2) Past history of the mental disease
3) Possiblity of the pregnancy
4) Possible participants whom it is judged to be inappropriate as a subjects

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tetsuaki Kawase

Organization

Tohoku University Graduate School of Biomedical Engineering / Graduate School of Medicine

Division name

audiology

Zip code


Address

1-1 Seiryo-machi, Aoba-ku, Sendai

TEL

022-717-7303

Email

kawase@orl.med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tetsuaki Kawase

Organization

Tohoku University Graduate School of Biomedical Engineering / Graduate School of Medicine

Division name

audiology

Zip code


Address

1-1 Seiryo-machi, Aoba-ku, Sendai

TEL

022-717-7303

Homepage URL


Email

kawase@orl.med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Tohoku University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Terminated

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 10 Month 15 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 10 Month 01 Day

Last modified on

2017 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022168


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name